Table 4.
Inhibition of the growth of various solid tumor cell lines
Cell line | IC50 of 6-substituted purine nucleoside analog (µM) | ||
---|---|---|---|
12 | 15 | 16 | |
SNB7 (CNS) | 33 | 31 | 10 |
DLD-1 (colon) | 170 | 6 | 0.9 |
NCI-H23 (lung) | 1 | 1.2 | 0.6 |
ZR-75-1 (mammary) | 23 | 1.2 | 0.3 |
LOXIMVI (melanoma) | >200 | 6.2 | 0.3 |
PC-3 (prostate) | 67 | 1.2 | 0.9 |
CAKI-1 (renal) | >200 | 31 | 30 |
The above cells were plated in 96-well microtiter plates and incubated with various concentrations of compound number 12, 15, or 16 at 37 °C. Cell viability was measured after 72 hours of continuous incubation with compound using the sulforhodamine B assay (absorbance read at 570 nm), and the concentration of compound that inhibited cell growth by 50% was determined. The results shown are the result of one experiment.